A hospital outbreak of carbapenem-resistant Enterobacteriaceae (CRE) became more worrisome when researchers found resistance genes being shared among unrelated bacteria via plasmids and other mobile genetic elements. This new research will be presented at ASM Microbe, the annual meeting of the American Society for Microbiology, held June 7-11 in Atlanta.
In 2017, eighteen patients in a primary care hospital became sick with CRE, a family of bacteria responsible for more than 9,000 healthcare-associated infections (HAI) per year in the United States. Carbapenems are often used as last line treatment options, reserved for the sickest patients; so it is concerning when bacteria resistant to these drugs cause infections.
Outbreaks of CRE infections are often caused by closely related bacteria spreading from person-to-person or even from a common source, such as a contaminated medical device. In such cases, infection control efforts focus on eliminating transmission of a single strain of bacteria. In this outbreak, however, multiple types of CRE (i.e., different bacterial strains and species) were infecting patients, and whole genome sequencing revealed that the outbreak was likely perpetuated by carbapenem resistance genes being shared among unrelated bacteria via plasmids or other mobile genetic elements.
"This demonstrates the important role whole genome sequencing can play in investigating HAI outbreaks," said Richard Stanton, "This outbreak shows us how drug resistance genes can be shared among otherwise unrelated bacteria co-existing in a patient's microbial community or in the environment." This in turn may require expanding infection control and detection efforts to include multiple strains and species to halt the outbreak.
The bacteria involved in this outbreak included Klebsiella pneumonia and Escherichia coli, two species of bacteria that can cause a variety of healthcare-associated infections, including pneumonia, bloodstream infections, surgical site infections, and meningitis. Treatment of the infections in these outbreaks was complicated due to the presence of carbapenemase genes in the bacteria, of which two major variants of the Klebsiella pneumonia Carbapenemase (KPC) gene (KPC-2 and KPC-3) were found.
The bacterial strains with the KPC-2 gene were largely unrelated but all carried the same drug resistance plasmid. Similarly, the strains with the KPC-3 gene were quite diverse except they all shared a plasmid, common among the KPC-3 strains but different from the KPC-2 strains.
"Due in part to this finding, HAI investigations now include a broader scope to look not just for single species causing infections, but also for plasmids spreading drug resistance across multiple types of bacteria," said Dr. Stanton. Infection control efforts also focus on areas where plasmid sharing is likely to occur in the healthcare environment, such as in sinks and drains.
Vaneet Arora, Lorrie Sims, and Rachel Zinner from the Kentucky Department for Public Health isolated and cultured the bacterial samples used in this study. Jonathan Daniels, Alison Laufer Halpin, and Richard Stanton from the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention performed whole genome sequencing and analysis of the isolates.
This work was made possible through CDC's investments to Combat Antibiotic Resistant Bacteria and the Advanced Molecular Detection Program at CDC.
Source: American Society for Microbiology
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
2 Commerce Drive
Cranbury, NJ 08512